A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antivirals.
A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antivirals.
复制标题
DOI:
10.1016/j.antiviral.2013.05.017
复制
发表时间:
2013-09
影响因子:
7.6
通讯作者:
Feldmann, Heinz
中科院分区:
文献类型:
--
作者:
Hoenen, Thomas;Groseth, Allison;Callison, Julie;Takada, Ayato;Feldmann, Heinz
Ebola virus (EBOV) causes a severe hemorrhagic fever with case fatality rates of up to 90%, for which no antiviral therapies are available. Antiviral screening is hampered by the fact that development of cytopathic effect, the easiest means to detect infection with wild-type EBOV, is relatively slow. To overcome this problem we generated a recombinant EBOV carrying a luciferase reporter. Using this virus we show that EBOV entry is rapid, with viral protein expression detectable within 2 hours after infection. Further, luminescence-based assays were developed to allow highly sensitive titer determination within 48 hours. As a proof-of-concept for its utility in antiviral screening we used this virus to assess neutralizing antibodies and siRNAs, with significantly faster screening times than currently available wild-type or recombinant viruses. The availability of this recombinant virus will allow for more rapid and quantitative evaluation of antivirals against EBOV, as well as the study of details of the EBOV life cycle.
登录
查看更多内容
影响因子:
5.4
作者:
Hoenen, Thomas;Shabman, Reed S.;Feldmann, Heinz
通讯作者:
Feldmann, Heinz
影响因子:
7.6
作者:
Panchal, Rekha G.;Reid, St. Patrick;Bavari, Sina
通讯作者:
Bavari, Sina
DOI:
10.1016/s0140-6736(10)60357-1
发表时间:
2010-05-29
期刊:
Lancet (London, England)
影响因子:
--
作者:
Geisbert TW;Lee AC;Robbins M;Geisbert JB;Honko AN;Sood V;Johnson JC;de Jong S;Tavakoli I;Judge A;Hensley LE;Maclachlan I
通讯作者:
Maclachlan I
影响因子:
168.9
作者:
Feldmann, Heinz;Geisbert, Thomas W.
通讯作者:
Geisbert, Thomas W.
影响因子:
--
作者:
Thorne N;Inglese J;Auld DS
通讯作者:
Auld DS